DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs

Go Oshima, Elizabeth C. Poli, Michael J. Bolt, Alexandre Chlenski, Martin Forde, Jessica M.S. Jutzy, Neha Biyani, Mitchell C. Posner, Sean P. Pitroda, Ralph R. Weichselbaum, Nikolai N. Khodarev

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Expression of 14q32-encoded miRNAs is a favorable prognostic factor in patients with metastatic cancer. In this study, we used genomic inhibition of DNA methylation through disruption of DNA methyltransferases DNMT1 and DNMT3B and pharmacologic inhibition with 5-Aza-20-deoxycytidine (5-Aza-dC, decitabine) to demonstrate that DNA methylation predominantly regulates expression of metastasis-suppressive miRNAs in the 14q32 cluster. DNA demethylation facilitated CCCTC-binding factor (CTCF) recruitment to the maternally expressed gene 3 differentially methylated region (MEG3-DMR), which acts as a cis-regulatory element for 14q32 miRNA expression. 5-Aza-dC activated demethylation of the MEG3-DMR and expression of 14q32 miRNAs, which suppressed adhesion, invasion, and migration (AIM) properties of metastatic tumor cells. Cancer cells with MEG3-DMR hypomethylation exhibited constitutive expression of 14q32 miRNAs and resistance to 5-Aza-dC-induced suppression of AIM. Expression of methylation-dependent 14q32 miRNAs suppressed metastatic colonization in preclinical models of lung and liver metastasis and correlated with improved clinical outcomes in patients with metastatic cancer. These findings implicate epigenetic modification via DNA methylation in the regulation of metastatic propensity through miRNA networks and identify a previously unrecognized action of decitabine on the activation of metastasis-suppressive miRNAs.

Original languageEnglish
Pages (from-to)650-662
Number of pages13
JournalCancer Research
Volume79
Issue number3
DOIs
Publication statusPublished - 2019 Jan 1
Externally publishedYes

Fingerprint

DNA Methylation
MicroRNAs
Neoplasm Metastasis
decitabine
Neoplasms
Genes
Deoxycytidine
DNA
Methyltransferases
Epigenomics
Methylation
Lung
Liver

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Oshima, G., Poli, E. C., Bolt, M. J., Chlenski, A., Forde, M., Jutzy, J. M. S., ... Khodarev, N. N. (2019). DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs. Cancer Research, 79(3), 650-662. https://doi.org/10.1158/0008-5472.CAN-18-0692

DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs. / Oshima, Go; Poli, Elizabeth C.; Bolt, Michael J.; Chlenski, Alexandre; Forde, Martin; Jutzy, Jessica M.S.; Biyani, Neha; Posner, Mitchell C.; Pitroda, Sean P.; Weichselbaum, Ralph R.; Khodarev, Nikolai N.

In: Cancer Research, Vol. 79, No. 3, 01.01.2019, p. 650-662.

Research output: Contribution to journalArticle

Oshima, G, Poli, EC, Bolt, MJ, Chlenski, A, Forde, M, Jutzy, JMS, Biyani, N, Posner, MC, Pitroda, SP, Weichselbaum, RR & Khodarev, NN 2019, 'DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs', Cancer Research, vol. 79, no. 3, pp. 650-662. https://doi.org/10.1158/0008-5472.CAN-18-0692
Oshima, Go ; Poli, Elizabeth C. ; Bolt, Michael J. ; Chlenski, Alexandre ; Forde, Martin ; Jutzy, Jessica M.S. ; Biyani, Neha ; Posner, Mitchell C. ; Pitroda, Sean P. ; Weichselbaum, Ralph R. ; Khodarev, Nikolai N. / DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs. In: Cancer Research. 2019 ; Vol. 79, No. 3. pp. 650-662.
@article{63af5f6461e849a0b779f6e4188ca76d,
title = "DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs",
abstract = "Expression of 14q32-encoded miRNAs is a favorable prognostic factor in patients with metastatic cancer. In this study, we used genomic inhibition of DNA methylation through disruption of DNA methyltransferases DNMT1 and DNMT3B and pharmacologic inhibition with 5-Aza-20-deoxycytidine (5-Aza-dC, decitabine) to demonstrate that DNA methylation predominantly regulates expression of metastasis-suppressive miRNAs in the 14q32 cluster. DNA demethylation facilitated CCCTC-binding factor (CTCF) recruitment to the maternally expressed gene 3 differentially methylated region (MEG3-DMR), which acts as a cis-regulatory element for 14q32 miRNA expression. 5-Aza-dC activated demethylation of the MEG3-DMR and expression of 14q32 miRNAs, which suppressed adhesion, invasion, and migration (AIM) properties of metastatic tumor cells. Cancer cells with MEG3-DMR hypomethylation exhibited constitutive expression of 14q32 miRNAs and resistance to 5-Aza-dC-induced suppression of AIM. Expression of methylation-dependent 14q32 miRNAs suppressed metastatic colonization in preclinical models of lung and liver metastasis and correlated with improved clinical outcomes in patients with metastatic cancer. These findings implicate epigenetic modification via DNA methylation in the regulation of metastatic propensity through miRNA networks and identify a previously unrecognized action of decitabine on the activation of metastasis-suppressive miRNAs.",
author = "Go Oshima and Poli, {Elizabeth C.} and Bolt, {Michael J.} and Alexandre Chlenski and Martin Forde and Jutzy, {Jessica M.S.} and Neha Biyani and Posner, {Mitchell C.} and Pitroda, {Sean P.} and Weichselbaum, {Ralph R.} and Khodarev, {Nikolai N.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-18-0692",
language = "English",
volume = "79",
pages = "650--662",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs

AU - Oshima, Go

AU - Poli, Elizabeth C.

AU - Bolt, Michael J.

AU - Chlenski, Alexandre

AU - Forde, Martin

AU - Jutzy, Jessica M.S.

AU - Biyani, Neha

AU - Posner, Mitchell C.

AU - Pitroda, Sean P.

AU - Weichselbaum, Ralph R.

AU - Khodarev, Nikolai N.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Expression of 14q32-encoded miRNAs is a favorable prognostic factor in patients with metastatic cancer. In this study, we used genomic inhibition of DNA methylation through disruption of DNA methyltransferases DNMT1 and DNMT3B and pharmacologic inhibition with 5-Aza-20-deoxycytidine (5-Aza-dC, decitabine) to demonstrate that DNA methylation predominantly regulates expression of metastasis-suppressive miRNAs in the 14q32 cluster. DNA demethylation facilitated CCCTC-binding factor (CTCF) recruitment to the maternally expressed gene 3 differentially methylated region (MEG3-DMR), which acts as a cis-regulatory element for 14q32 miRNA expression. 5-Aza-dC activated demethylation of the MEG3-DMR and expression of 14q32 miRNAs, which suppressed adhesion, invasion, and migration (AIM) properties of metastatic tumor cells. Cancer cells with MEG3-DMR hypomethylation exhibited constitutive expression of 14q32 miRNAs and resistance to 5-Aza-dC-induced suppression of AIM. Expression of methylation-dependent 14q32 miRNAs suppressed metastatic colonization in preclinical models of lung and liver metastasis and correlated with improved clinical outcomes in patients with metastatic cancer. These findings implicate epigenetic modification via DNA methylation in the regulation of metastatic propensity through miRNA networks and identify a previously unrecognized action of decitabine on the activation of metastasis-suppressive miRNAs.

AB - Expression of 14q32-encoded miRNAs is a favorable prognostic factor in patients with metastatic cancer. In this study, we used genomic inhibition of DNA methylation through disruption of DNA methyltransferases DNMT1 and DNMT3B and pharmacologic inhibition with 5-Aza-20-deoxycytidine (5-Aza-dC, decitabine) to demonstrate that DNA methylation predominantly regulates expression of metastasis-suppressive miRNAs in the 14q32 cluster. DNA demethylation facilitated CCCTC-binding factor (CTCF) recruitment to the maternally expressed gene 3 differentially methylated region (MEG3-DMR), which acts as a cis-regulatory element for 14q32 miRNA expression. 5-Aza-dC activated demethylation of the MEG3-DMR and expression of 14q32 miRNAs, which suppressed adhesion, invasion, and migration (AIM) properties of metastatic tumor cells. Cancer cells with MEG3-DMR hypomethylation exhibited constitutive expression of 14q32 miRNAs and resistance to 5-Aza-dC-induced suppression of AIM. Expression of methylation-dependent 14q32 miRNAs suppressed metastatic colonization in preclinical models of lung and liver metastasis and correlated with improved clinical outcomes in patients with metastatic cancer. These findings implicate epigenetic modification via DNA methylation in the regulation of metastatic propensity through miRNA networks and identify a previously unrecognized action of decitabine on the activation of metastasis-suppressive miRNAs.

UR - http://www.scopus.com/inward/record.url?scp=85060938507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060938507&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-18-0692

DO - 10.1158/0008-5472.CAN-18-0692

M3 - Article

C2 - 30538122

AN - SCOPUS:85060938507

VL - 79

SP - 650

EP - 662

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 3

ER -